AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 JUL 24 - (NewsRx.com & NewsRx.net) -- Latest data show that measles mumps rubella (MMR) vaccine uptake in 16- and 24-month-old U.K. children fell over the winter period but then increased in April 2002. This dip was likely to be associated in large part with the intense adverse publicity about MMR over the Christmas and New Year period, which was around the time that the 16-month-old children were scheduled to receive their first dose of MMR.
Children are scheduled to receive their first dose of MMR at around 12-15 months of age. National routine monitoring of vaccination uptake normally takes place for children at ages 2 and 5 years. The latest routine data published for children age 2 years in the U.K. stands at 84%; however these children were scheduled to receive their first dose of MMR around a year ago. So to gain a more timely picture of MMR coverage, monitoring of a smaller sample of children from across England at 16 and 24 months of age is also carried out.
Uptake fell for children age 16 months from 76.2% in December 2001 to 70.1% in March 2002. However, the latest figures show that uptake at this age had risen again to 72.0% by April 2002.
"We frequently see falls in vaccine uptake associated with periods of adverse publicity, but the falls are usually temporary and followed by a degree of recovery," said Dr. Mary Ramsay of the Public Health Laboratory Service (PHLS). ...